The Honest
HNST
4.93
-0.10
-1.99%
The Honest
US · HNST
#3709 by market cap
Listed 2021
4.93
-0.10
-1.99%
Live - 5344 symbols - heartbeat 321s ago
· 2026-10-08 09:16
Pre-market
4.91
-0.49%
After-hours
4.96
+0.57%
Overnight
4.93
0.00%
- Market cap
- 528.91M
- P/E (TTM)i
- -44.82
- P/Bi
- 3.17
- EPSi
- -0.14
- Div yieldi
- 0.00%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on HNST?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.83, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year -1.86% YoY
Margins
- Gross margin
- 33.33%
- Operating margin
- -3.85%
- Net margin
- -4.22%
Key ratios & quality
- Altman Z-Scorei
- 4.83
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 235.59M | 300.52M | 318.64M | 313.65M | 344.37M | 378.34M | 371.32M |
| Gross profit | 75.85M | 107.90M | 109.17M | 92.32M | 100.53M | 144.66M | 123.76M |
| Selling & admin expenses | 102.17M | 115.73M | 138.32M | 135.10M | 131.02M | 144.14M | 130.71M |
| Research & development | 5.14M | 5.71M | 7.68M | 7.00M | 6.21M | 6.85M | 7.35M |
| Operating profit | -31.46M | -13.54M | -36.83M | -49.78M | -36.70M | -6.33M | -14.30M |
| Pretax profit | -31.03M | -14.38M | -38.60M | -48.91M | -39.16M | -6.05M | -15.48M |
| Tax | 55.00K | 89.00K | 77.00K | 110.00K | 75.00K | 75.00K | 204.00K |
| Net profit | -31.08M | -14.47M | -38.68M | -49.02M | -39.24M | -6.12M | -15.69M |
| Basic EPS | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Diluted EPS | -0.36 | -0.17 | -0.43 | -0.53 | -0.42 | -0.06 | -0.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 97.25M | 93.46M | 92.57M | 88.04M | 78.10M | 83.30M |
| Gross profit | 37.67M | 37.75M | 34.49M | 13.84M | 33.27M | 40.36M |
| Selling & admin expenses | 33.31M | 32.90M | 32.48M | 32.02M | 31.46M | 29.44M |
| Research & development | 1.85M | 1.96M | 1.70M | 1.83M | 1.86M | 1.72M |
| Operating profit | 2.51M | 2.89M | 313.00K | -20.01M | -53.00K | 9.20M |
| Pretax profit | 3.29M | 3.91M | 868.00K | -23.56M | 4.00K | 10.75M |
| Tax | 40.00K | 44.00K | 110.00K | 9.00K | 46.00K | 65.00K |
| Net profit | 3.25M | 3.87M | 758.00K | -23.57M | -42.00K | 10.69M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.03 | 0.03 | 0.01 | -0.21 | 0.00 | 0.09 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 167.89M | 173.56M | 213.80M | 189.15M | 157.77M | 213.92M | 202.43M |
| Cash & ST investments | 85.02M | 63.68M | 93.18M | 15.17M | 32.83M | 75.44M | 89.58M |
| Inventory | 52.54M | 76.67M | 75.67M | 115.66M | 73.49M | 85.27M | 72.50M |
| Total assets | 234.02M | 240.73M | 272.60M | 240.60M | 201.62M | 247.39M | 225.41M |
| Total current liabilities | 38.69M | 54.07M | 48.48M | 63.58M | 56.71M | 59.89M | 50.82M |
| Short-term debt | -- | -- | -- | 7.69M | 8.11M | 8.54M | 9.04M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 464,299,000.00 | 477,557,000.00 | 93,491,000.00 | 94,239,000.00 | 78,482,000.00 | 73,086,000.00 | 55,738,000.00 |
| Total equity | -230.28M | -236.83M | 179.11M | 146.36M | 123.14M | 174.31M | 169.67M |
| Retained earnings | -338.51M | -352.98M | -391.66M | -439.83M | -479.07M | -485.19M | -500.88M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 234.62M | 220.91M | 216.16M | 202.43M | 192.81M | 200.67M |
| Cash & ST investments | 72.82M | 72.08M | 71.45M | 89.58M | 90.37M | 105.90M |
| Inventory | 90.26M | 95.03M | 93.85M | 72.50M | 61.18M | 49.66M |
| Total assets | 265.30M | 249.03M | 241.54M | 225.41M | 214.92M | 220.12M |
| Total current liabilities | 73.96M | 53.26M | 44.87M | 50.82M | 42.75M | 50.90M |
| Short-term debt | 8.65M | 8.77M | 8.88M | 9.04M | 8.69M | 7.30M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 84,947,000.00 | 62,000,000.00 | 51,354,000.00 | 55,738,000.00 | 45,829,000.00 | 53,104,000.00 |
| Total equity | 180.36M | 187.03M | 190.19M | 169.67M | 169.09M | 167.02M |
| Retained earnings | -481.94M | -478.07M | -477.31M | -500.88M | -500.92M | -490.23M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -19.99M | -12.07M | -38.15M | -76.28M | 19.35M | 1.54M | 15.12M |
| Depreciation & amortization | 7.67M | 4.85M | 4.15M | 8.93M | 9.00M | 9.29M | 9.55M |
| Free cash flow | -20.65M | -12.27M | -38.37M | -77.89M | 17.51M | 1.01M | 13.61M |
| Dividends paid | 0 | 0 | -35.00M | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 96.52M | -- | -- | -- | -- |
| Ending cash balance | 13.54M | 37.20M | 50.79M | 9.52M | 32.83M | 75.44M | 89.58M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.94M | -745.00K | -504.00K | 19.31M | 5.52M | 32.25M |
| Depreciation & amortization | 2.36M | 2.39M | 2.39M | 2.41M | 2.32M | 2.30M |
| Free cash flow | -3.00M | -826.00K | -624.00K | 18.06M | 3.79M | 31.49M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -3.00M | -16.06M |
| Ending cash balance | 72.82M | 72.08M | 71.45M | 89.58M | 90.37M | 105.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -30.12 | -29.12 | -4.12 | -9.12 |
| ROA %i | -13.28 | 0.76 | -11.81 | -19.10 | -17.75 | -2.73 | -6.64 |
| ROIC %i | -- | -- | -- | -24.21 | -23.17 | -3.51 | -8.26 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -13.35 | -4.51 | -11.56 | -15.87 | -11.29 | -1.67 | -3.85 |
| FCF / sales %i | -- | -- | -- | -- | 5.08 | 0.27 | 3.67 |
| Current ratioi | 4.34 | 3.21 | 4.41 | 2.97 | 2.78 | 3.57 | 3.98 |
| Quick ratioi | 2.82 | 1.60 | 2.58 | 0.90 | 1.34 | 1.99 | 2.43 |
| Debt / assetsi | 16.76 | 15.96 | 13.77 | 15.60 | 14.80 | 8.79 | 6.19 |
| LT debt / equityi | -- | -- | 20.95 | 20.39 | 17.65 | 7.57 | 2.90 |
| Interest coveragei | -- | -- | -- | -- | -144.59 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 10.01 | 4.64 | 5.89 | 5.79 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -0.96 | 4.09 | 4.37 | -9.12 | -10.86 | -6.87 |
| ROA %i | -0.63 | 2.88 | 3.14 | -6.64 | -7.91 | -5.19 |
| ROIC %i | -0.83 | 3.60 | 3.89 | -8.26 | -9.97 | -6.38 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.64 | 1.13 | 1.22 | -3.85 | -4.79 | -3.09 |
| FCF / sales %i | -- | -- | -- | 3.67 | 5.79 | 15.41 |
| Current ratioi | 3.17 | 4.15 | 4.82 | 3.98 | 4.51 | 3.94 |
| Quick ratioi | 1.56 | 2.20 | 2.56 | 2.43 | 2.91 | 2.83 |
| Debt / assetsi | 7.40 | 7.03 | 6.36 | 6.19 | 5.47 | 4.32 |
| LT debt / equityi | 6.09 | 4.67 | 3.41 | 2.90 | 1.82 | 1.32 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Creating cleanly-formulated and sustainably-designed products100.00%
Quote time 2026-10-08 09:16:58 · For reference only, not investment advice and not tailored to your situation.